Skip to main content
Top
Published in: Journal of Mammary Gland Biology and Neoplasia 1/2023

Open Access 01-12-2023 | Breast Cancer | Research

High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells

Authors: Wintana Balema, Janelle Morton, Richard A. Larson, Li Li, Fred Christian Velasquez, Natalie W. Fowlkes, Savitri Krishnamurthy, Bisrat G. Debeb, Eva Sevick-Muraca, Wendy A. Woodward

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 1/2023

Login to get access

Abstract

Inflammatory breast cancer (IBC) presents as rapid-onset swelling and breast skin changes caused by tumor emboli in the breast and breast skin lymphatics. IBC has been linked with obesity and duration of breastfeeding, but how these factors affect IBC tumor progression is not clear. We modeled the simultaneous effects of diet and weaning in mice on in vivo lymphatic function; on IBC tumor growth; and on aspects of the mammary gland microenvironment before and after IBC (SUM149) xenograft inoculation. We hypothesized that weaning status and diet would have synergistic effects on lymphatic function and the breast microenvironment to enhance IBC tumor growth. Changes in lymphatic structure and function were characterized with in vivo near-infrared fluorescence (NIRF) imaging. Mice were fed either a high-fat diet (HFD; 60 kcal%) or a normal/low-fat diet (LFD; 10 kcal%), bred twice, and subjected to either normal-duration nursing (NW) or forced weaning (FW). SUM149 IBC tumors were implanted at 14 months; images were obtained before and after implantation. Multiparous mice fed HFD showed increased pre-tumor lymphatic pulsing in both the FW and NW groups relative to mice fed LFD. HFD promoted tumor growth independent of weaning time (P = 0.04). Pre-tumor lymphatic pulsing was associated with tumor volume at 8 weeks (P = 0.02) and was significantly correlated with expression of the lymphatic tracking ligand CCL21 (P = 0.05, Table 1). HFD significantly increased the numbers of monocyte-derived IBA1+, CD163+, and CD11c+ cells (P < 0.0001, P < 0.0001, P = 0.0005) in the contralateral, non-tumor-bearing mammary gland. Numbers of lymphangiogenic podoplanin+/IBA1+ macrophages were increased in the ducts of HFD and FW mice (all P < 0.003). HFD in nulliparous mice had a similar increase in lymphatic pulsing at 14 weeks (P = 0.006), indicating that this functional change was independent of parity. We conclude that HFD induced increases in mammary gland lymphatic function, assessed as pulsing rate before tumor initiation, and correlated with inflammation in the mammary gland and increased SUM149 tumor growth. The relationship between diet, lymphatic pulsing, and tumor growth warrants further investigation.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, Jagsi R, Lang JE, Alpaugh M, Smith K, Miller K. Abstract P6–15–03: Inflammatory breast cancer (IBC) defined: Proposed common diagnostic criteria and scoring - Moving beyond the subjective ‘clinical diagnosis’ of IBC to advance research. Cancer Res. 2020;80(4):6–15. https://doi.org/10.1158/1538-7445.SABCS19-P6-15-03.CrossRef Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, Jagsi R, Lang JE, Alpaugh M, Smith K, Miller K. Abstract P6–15–03: Inflammatory breast cancer (IBC) defined: Proposed common diagnostic criteria and scoring - Moving beyond the subjective ‘clinical diagnosis’ of IBC to advance research. Cancer Res. 2020;80(4):6–15. https://​doi.​org/​10.​1158/​1538-7445.​SABCS19-P6-15-03.CrossRef
3.
go back to reference Barkataki S, Javadekar MJ, Bradfield P, Murphy T, Witmer DD, Van Golen KL. Inflammatory breast cancer: a panoramic overview. J Rare Dis Res Treat. 2018;3(2):37–43.CrossRef Barkataki S, Javadekar MJ, Bradfield P, Murphy T, Witmer DD, Van Golen KL. Inflammatory breast cancer: a panoramic overview. J Rare Dis Res Treat. 2018;3(2):37–43.CrossRef
5.
go back to reference Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th anniversary conference. J Cancer. 2018;9(8):1437–47. https://doi.org/10.7150/jca.23969.CrossRefPubMedPubMedCentral Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th anniversary conference. J Cancer. 2018;9(8):1437–47. https://​doi.​org/​10.​7150/​jca.​23969.CrossRefPubMedPubMedCentral
12.
go back to reference Sharma R, Wang W, Rasmusssen JC, Joshi A, Houston JP, Adams KE, Cameron A, Ke S, Kwon S, Mawad ME, Sevick-Muraca E. Quantitative imaging of lymphatic function. Am J Physiol Heart Circ Physiol. 2007;292(6):H3109-3118.CrossRefPubMed Sharma R, Wang W, Rasmusssen JC, Joshi A, Houston JP, Adams KE, Cameron A, Ke S, Kwon S, Mawad ME, Sevick-Muraca E. Quantitative imaging of lymphatic function. Am J Physiol Heart Circ Physiol. 2007;292(6):H3109-3118.CrossRefPubMed
14.
go back to reference Reddy JP, Atkinson RL, Larson R, Burks JK, Smith D, Debeb BG, Ruffell B, Creighton CJ, Bambhroliya A, Reuben JM, Van Laere SJ, Krishnamurthy S, Symmans WF, Brewster AM, Woodward WA. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Res Treat. 2018;171(2):283–93. https://doi.org/10.1007/s10549-018-4835-6.CrossRefPubMed Reddy JP, Atkinson RL, Larson R, Burks JK, Smith D, Debeb BG, Ruffell B, Creighton CJ, Bambhroliya A, Reuben JM, Van Laere SJ, Krishnamurthy S, Symmans WF, Brewster AM, Woodward WA. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Res Treat. 2018;171(2):283–93. https://​doi.​org/​10.​1007/​s10549-018-4835-6.CrossRefPubMed
18.
go back to reference Bieniasz-Krzywiec P, Martín-Pérez R, Ehling M, García-Caballero M, Pinioti S, Pretto S, Kroes R, Aldeni C, Di Matteo M, Prenen H, Tribulatti MV, Campetella O, Smeets A, Noel A, Floris G, Van Ginderachter JA, Mazzone M. Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer. Cell Metab. 2019;30(5):917-936.e10. https://doi.org/10.1016/j.cmet.2019.07.015.CrossRefPubMed Bieniasz-Krzywiec P, Martín-Pérez R, Ehling M, García-Caballero M, Pinioti S, Pretto S, Kroes R, Aldeni C, Di Matteo M, Prenen H, Tribulatti MV, Campetella O, Smeets A, Noel A, Floris G, Van Ginderachter JA, Mazzone M. Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer. Cell Metab. 2019;30(5):917-936.e10. https://​doi.​org/​10.​1016/​j.​cmet.​2019.​07.​015.CrossRefPubMed
Metadata
Title
High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells
Authors
Wintana Balema
Janelle Morton
Richard A. Larson
Li Li
Fred Christian Velasquez
Natalie W. Fowlkes
Savitri Krishnamurthy
Bisrat G. Debeb
Eva Sevick-Muraca
Wendy A. Woodward
Publication date
01-12-2023
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 1/2023
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-023-09548-8

Other articles of this Issue 1/2023

Journal of Mammary Gland Biology and Neoplasia 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine